Hound Partners’s Freeline Therapeutics Holdings FRLN Stock Holding History
Bought
Maintained
Sold
Other funds holding FRLN
Hound Partners's FRLN Position: Q4 2020 in Review
Hound Partners sold out of Freeline Therapeutics Holdings (FRLN) in Q4 2020, closing a stake of 4,667 shares — an estimated $1.09M sold.
Hound Partners first reported a position in FRLN in Q3 2020 and held it in 1 quarter. The position peaked at $1.09M in Q3 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q4 2020.
- Hound Partners reported no remaining Freeline Therapeutics Holdings position as of Q4 2020 after selling out during the quarter.
- Hound Partners sold 4,667 Freeline Therapeutics Holdings shares in Q4 2020, an estimated $1.09M.
- Hound Partners first reported a position in Freeline Therapeutics Holdings in Q3 2020 and held it in 1 quarter.
- Hound Partners's Freeline Therapeutics Holdings position peaked at $1.09M in Q3 2020.
- 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings as of Q4 2020.
Based on Hound Partners's 13F filing for Q4 2020, filed 16 Feb 2021.